178 related articles for article (PubMed ID: 38302465)
1. Multiplexed screening reveals how cancer-specific alternative polyadenylation shapes tumor growth in vivo.
Gabel AM; Belleville AE; Thomas JD; McKellar SA; Nicholas TR; Banjo T; Crosse EI; Bradley RK
Nat Commun; 2024 Feb; 15(1):959. PubMed ID: 38302465
[TBL] [Abstract][Full Text] [Related]
2. Tempo-spatial alternative polyadenylation analysis reveals that 3' UTR lengthening of Mdm2 regulates p53 expression and cellular senescence in aged rat testis.
Wang L; Chen M; Fu H; Ni T; Wei G
Biochem Biophys Res Commun; 2020 Mar; 523(4):1046-1052. PubMed ID: 31973811
[TBL] [Abstract][Full Text] [Related]
3. Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer.
Kim N; Chung W; Eum HH; Lee HO; Park WY
PLoS One; 2019; 14(5):e0217196. PubMed ID: 31100099
[TBL] [Abstract][Full Text] [Related]
4. APA-Scan: detection and visualization of 3'-UTR alternative polyadenylation with RNA-seq and 3'-end-seq data.
Fahmi NA; Ahmed KT; Chang JW; Nassereddeen H; Fan D; Yong J; Zhang W
BMC Bioinformatics; 2022 Sep; 23(Suppl 3):396. PubMed ID: 36171568
[TBL] [Abstract][Full Text] [Related]
5. Modulation of untranslated region alternative polyadenylation in glioma tumorigenesis.
Lan YL; Zhang J
Biomed Pharmacother; 2021 May; 137():111416. PubMed ID: 33761620
[TBL] [Abstract][Full Text] [Related]
6. Recurrent tumor-specific regulation of alternative polyadenylation of cancer-related genes.
Xue Z; Warren RL; Gibb EA; MacMillan D; Wong J; Chiu R; Hammond SA; Yang C; Nip KM; Ennis CA; Hahn A; Reynolds S; Birol I
BMC Genomics; 2018 Jul; 19(1):536. PubMed ID: 30005633
[TBL] [Abstract][Full Text] [Related]
7. The Transcriptional Landscape of Immune-Response 3'-UTR Alternative Polyadenylation in Melanoma.
Yang X; Wu Y; Chen X; Qiu J; Huang C
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474285
[TBL] [Abstract][Full Text] [Related]
8. Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma.
Venkat S; Tisdale AA; Schwarz JR; Alahmari AA; Maurer HC; Olive KP; Eng KH; Feigin ME
Genome Res; 2020 Mar; 30(3):347-360. PubMed ID: 32029502
[TBL] [Abstract][Full Text] [Related]
9. CstF64-Induced Shortening of the
Lin A; Ji P; Niu X; Zhao X; Chen Y; Liu W; Liu Y; Fan W; Sun Y; Miao C; Zhang S; Tan W; Lin D; Wagner EJ; Wu C
Cancer Res; 2021 Nov; 81(22):5638-5651. PubMed ID: 34607841
[TBL] [Abstract][Full Text] [Related]
10. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
[TBL] [Abstract][Full Text] [Related]
11. Shortening of 3' UTRs in most cell types composing tumor tissues implicates alternative polyadenylation in protein metabolism.
Burri D; Zavolan M
RNA; 2021 Dec; 27(12):1459-1470. PubMed ID: 34521731
[TBL] [Abstract][Full Text] [Related]
12. Alternative polyadenylation dysregulation contributes to the differentiation block of acute myeloid leukemia.
Davis AG; Johnson DT; Zheng D; Wang R; Jayne ND; Liu M; Shin J; Wang L; Stoner SA; Zhou JH; Ball ED; Tian B; Zhang DE
Blood; 2022 Jan; 139(3):424-438. PubMed ID: 34482400
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of alternative polyadenylation in human preimplantation embryos.
Chang JY; Yu WH; Juan HF; Huang HC
Biochem Biophys Res Commun; 2018 Oct; 504(4):727-733. PubMed ID: 30217451
[TBL] [Abstract][Full Text] [Related]
14. Elimination of
Bae B; Gruner HN; Lynch M; Feng T; So K; Oliver D; Mastick GS; Yan W; Pieraut S; Miura P
RNA; 2020 Oct; 26(10):1414-1430. PubMed ID: 32522888
[TBL] [Abstract][Full Text] [Related]
15. Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers.
Wang L; Lang GT; Xue MZ; Yang L; Chen L; Yao L; Li XG; Wang P; Hu X; Shao ZM
Theranostics; 2020; 10(23):10531-10547. PubMed ID: 32929364
[No Abstract] [Full Text] [Related]
16. Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types.
Xia Z; Donehower LA; Cooper TA; Neilson JR; Wheeler DA; Wagner EJ; Li W
Nat Commun; 2014 Nov; 5():5274. PubMed ID: 25409906
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Immune-Related Alternative Polyadenylation Events in Cancer Immunotherapy.
Wang G; Xie Z; Su J; Chen M; Du Y; Gao Q; Zhang G; Zhang H; Chen X; Liu H; Han L; Ye Y
Cancer Res; 2022 Oct; 82(19):3474-3485. PubMed ID: 35930727
[TBL] [Abstract][Full Text] [Related]
18. Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.
Chu Y; Elrod N; Wang C; Li L; Chen T; Routh A; Xia Z; Li W; Wagner EJ; Ji P
Oncogene; 2019 May; 38(21):4154-4168. PubMed ID: 30705404
[TBL] [Abstract][Full Text] [Related]
19. Progressive lengthening of 3' untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development.
Ji Z; Lee JY; Pan Z; Jiang B; Tian B
Proc Natl Acad Sci U S A; 2009 Apr; 106(17):7028-33. PubMed ID: 19372383
[TBL] [Abstract][Full Text] [Related]
20. Alternative Polyadenylation of mRNAs: 3'-Untranslated Region Matters in Gene Expression.
Yeh HS; Yong J
Mol Cells; 2016 Apr; 39(4):281-5. PubMed ID: 26912084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
